/

Società

Ju

Non verificato

Juniper Biosciences

Di cosa scriviamo

BiotecnologiaFinanzaMedicina Salute Benessere

3 comunicati stampa

Guarda tutti i comunicati

18/05/2026

Biotecnologia

Juniper Biosciences Appoints Renowned Radiopharmaceutical Expert Jason S. Lewis, Ph.D. as Chair of Newly Formed Scientific Advisory Board

Fonte

Juniper Biosciences

Emittente

1.00

0

28/04/2026

Biotecnologia

Juniper Biosciences Announces Strategic Collaboration with leading global cancer center on F-MISO (JBS-003): A First-in-Class Precision Diagnostic Poised to Revolutionize Head and Neck Cancer Treatment

Fonte

Juniper Biosciences

Emittente

1.00

0

01/12/2025

Biotecnologia

Finanza

Medicina Salute Benessere

Juniper Biosciences Raises Oversubscribed and Upsized $40 Million Seed Financing to Fund Development of Its Innovative Pipeline

Fonte

Juniper Biosciences

Emittente

1.00

0

Seguaci

0

Compatibilità

0